Abstract
Although lapatinib-induced hepatotoxicity can cause severe clinical complications in patients, the factors affecting hepatotoxicity have rarely been investigated. The purpose of this study was to investigate risk factors for hepatotoxicity and time to lapatinib-induced hepatotoxicity. This retrospective study was performed on metastatic breast cancer patients treated with lapatinib. Various factors were evaluated for hepatotoxicity and time to hepatotoxicity, including sex, age, body weight, height, body surface area, underlying disease, smoking history, start dose of lapatinib, status of liver metastasis, and concomitant drugs. Among 159 patients, the percentage of patients with hepatotoxicity after lapatinib initiation was 57.9% (n = 92). Multivariate analysis showed that concomitant use of H2 blockers increased the incidence of hepatotoxicity by 2.3-fold. Patients who received CYP3A4 inducers had 3.1 times higher risk of hepatotoxicity incidence; the attributable risks of H2 blockers and CYP3A4 inducers were 56.7% and 68.1%, respectively. Use of H2 blockers increased the hazard of time to hepatotoxicity by 1.8-fold compared to non-use of H2 blockers. Our study demonstrated that concomitant use of H2 blockers and CYP3A4 induc...Continue Reading
References
Mar 1, 1991·British Journal of Cancer·W J GullickD G Altman
Dec 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·S NicholsonA L Harris
Jan 9, 1987·Science·D J SlamonW L McGuire
Jul 3, 2002·Current Drug Metabolism·C Ju, J P Uetrecht
Sep 6, 2002·Oncogene·Wenle XiaNeil L Spector
Jul 2, 2005·Critical Reviews in Toxicology·Jennie L WalgrenDavid C Thompson
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Henry L GomezGeorge W Sledge
Apr 18, 2009·British Journal of Clinical Pharmacology·Deborah A SmithAndrew Beelen
Mar 11, 2010·Pharmacogenetics and Genomics·Laura M HodgesRuss B Altman
Jul 14, 2010·Molecular Pharmacology·Woon Chien TengEric Chun Yong Chan
Jan 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Colin F SpraggsLon R Cardon
Apr 2, 2011·Nature Reviews. Drug Discovery·B Kevin ParkThomas A Baillie
Oct 4, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Stephen CastellinoChristopher MacLauchlin
Mar 1, 2012·Breast Cancer Research and Treatment·Yi Ling TeoAlexandre Chan
Mar 15, 2012·Pharmaceutical Research·Jane R KennyS Cyrus Khojasteh
Jun 29, 2012·Clinical Pharmacology and Therapeutics·N R BudhaJ A Ware
Apr 27, 2013·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Rashmi R ShahDevron R Shah
Nov 18, 2014·Expert Opinion on Drug Metabolism & Toxicology·Yi Ling TeoAlexandre Chan
Jul 28, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Joanna K TowlesKlarissa D Jackson
Citations
Feb 14, 2020·Expert Opinion on Drug Metabolism & Toxicology·Qiang ShiWilliam B Mattes
Aug 21, 2020·Archives of Toxicology·Guillermo García-LainezInmaculada Andreu
May 24, 2020·European Journal of Clinical Pharmacology·Ji Min HanHye Sun Gwak